text

Press Releases

content-image

LATEST NEWS

GenVivo Latest News

GenVivo Announces Initiation of Patient Dosing in a US Phase I/Ib Clinical Trial Evaluating GEN2, a Personalizing, Gene Vector Immunotherapy, in Patients with Advanced Solid Tumors

Jun 27, 2024
Read More >

GenVivo to Present Pipeline Programs at the 2024 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

May 8, 2024
Read More >

GenVivo to Present at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Apr 10, 2024
Read More >

GenVivo to Present at the 2024 BioProcess International (BPI) US West Annual Meeting

Mar 12, 2024
Read More >

GenVivo to Present at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 4, 2023
Read More >

GenVivo to Present at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

May 19, 2023
Read More >